This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.82% per year. These returns cover a period from January 1, 1988 through October 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
healthcare: Archive
Top Wide-Moat Stocks to Buy for Steady Long-Term Returns
by Anindya Barman
TSM, TXN, UNH and LMT use strong moats to fend off rivals and deliver consistent returns amid market shifts.
LMTNegative Net Change TXNNegative Net Change UNHNegative Net Change TSMPositive Net Change AAPLNegative Net Change NVDAPositive Net Change ASMLPositive Net Change
artificial-intelligence healthcare medical semiconductor
3 Portfolio-Worthy Stocks Hitting 52-Week Highs: AAPL, LLY & KO
by Shaun Pruitt
With market volatility and economic uncertainty keeping investors on edge, these established large-cap companies are demonstrating impressive relative strength.
AAPLNegative Net Change KONegative Net Change LLYNegative Net Change
artificial-intelligence computers consumer-staples dividend-investing dividends earnings economy electronics healthcare inflation investing large-cap medical pharmaceuticals stock-performance tech-stocks
Aging Population Boosts Healthcare REITs: Stocks to Watch
by Urmimala Biswas
Senior-housing occupancy reached 90.4% as limited construction and aging demographics create opportunities for Welltower, CareTrust REIT and LTC Properties.
LTCNegative Net Change CTREPositive Net Change WELLNegative Net Change OHIPositive Net Change ENSGNegative Net Change
healthcare medical medical-devices pharmaceuticals real-estate
UnitedHealth's Q3 Margins Improve, But Membership Falls: Time to Buy?
by Kaibalya Pravo Dey
UNH's Q3 earnings surge and improving margins signal a recovery, but falling membership and elevated utilization raise questions about sustained growth.
UNHNegative Net Change MOHNegative Net Change CNCNegative Net Change
earnings-report earnings-surprise healthcare hmo insurance medical
JNJ Q3 Earnings Call Highlights Growth Outlook and MedTech Challenges
by Zacks Equity Research
Johnson & Johnson raises its 2026 sales and earnings outlook as strong pharmaceutical growth offsets MedTech challenges, while 2027 dilution clouds the outlook.
JNJPositive Net Change
earnings healthcare medical-devices
Centene vs. Molina: Which Managed Care Stock Has More Upside?
by Rajshree Sipani
CNC's diversified business, improving margins and lower valuation give it an edge over MOH, with stronger earnings prospects and greater upside potential.
MOHNegative Net Change CNCNegative Net Change
artificial-intelligence automation earnings-surprise healthcare hmo insurance insurance-premium medical smart-health
UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge?
by Rajshree Sipani
UNH's diversified healthcare platform, improving Medicare Advantage profitability and lower valuation give it an edge over HUM.
UNHNegative Net Change HUMPositive Net Change
artificial-intelligence automation dividend dividend-yield earnings-surprise healthcare hmo hospitals insurance medical smart-health
UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock?
by Kaibalya Pravo Dey
UNH's Q3 earnings are expected to jump 41.1% despite revenue headwinds. Can improving cost management and restructuring drive further stock gains?
UNHNegative Net Change HUMPositive Net Change MOHNegative Net Change
earnings-preview healthcare hmo insurance medical
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy?
by Kaibalya Pravo Dey
CNC's improving Medicaid margins, stronger Marketplace profitability and earnings recovery support its valuation, but sustainability remains the key test.
CNCNegative Net Change UNHNegative Net Change ELVNegative Net Change
healthcare hmo insurance medical
Why Women-Run Companies Deserve a Place in Your Portfolio
by Shrabana Mukherjee
BMY, HALO, TGT, NEO and ROST stocks show how women-led companies are redefining growth with discipline, agility and results.
BMYNegative Net Change TGTPositive Net Change ROSTNegative Net Change HALONegative Net Change NEOPositive Net Change
finance healthcare medical